Published in Clin Infect Dis on April 01, 1992
Listeria pathogenesis and molecular virulence determinants. Clin Microbiol Rev (2001) 10.41
Management of listeriosis. Clin Microbiol Rev (1997) 2.17
Listeria monocytogenes infection in Israel and review of cases worldwide. Emerg Infect Dis (2002) 1.58
Infections in patients with inherited defects in phagocytic function. Clin Microbiol Rev (2003) 1.02
Rhombencephalitis Caused by Listeria monocytogenes in Humans and Ruminants: A Zoonosis on the Rise? Interdiscip Perspect Infect Dis (2010) 0.96
Nitric oxide is protective in listeric meningoencephalitis of rats. Infect Immun (2001) 0.91
Listeriosis in patients receiving biologic therapies. Eur J Clin Microbiol Infect Dis (2013) 0.89
Bay Y 3118, a new quinolone derivative, rapidly eradicates Listeria monocytogenes from infected mice and L929 cells. Antimicrob Agents Chemother (1994) 0.87
Sepsis and meningitis due to Listeria monocytogenes. Yonsei Med J (2007) 0.85
Comparative efficacies of antibiotics in a rat model of meningoencephalitis due to Listeria monocytogenes. Antimicrob Agents Chemother (1999) 0.82
Listeria monocytogenes following orthotopic liver transplantation: central nervous system involvement and review of the literature. World J Gastroenterol (2007) 0.80
Solitary supratentorial Listeria monocytogenes brain abscess in an immunocompromised patient. Proc (Bayl Univ Med Cent) (2015) 0.79
Clinical presentation and outcome in cases of listeriosis. Clin Infect Dis (1993) 0.78
Listeriosis due to infection with a catalase-negative strain of Listeria monocytogenes. J Clin Microbiol (2006) 0.77
Exendin-4 improves resistance to Listeria monocytogenes infection in diabetic db/db mice. J Vet Sci (2012) 0.75
Orthotopic Liver Transplantation: Is There a Risk for Listeria monocytogenes Infection? Case Rep Med (2010) 0.75
Unusual Listeria monocytogenes peritonitis in peritoneal dialysis patient with liver cirrhosis: a case report and review of literature. CEN Case Rep (2017) 0.75
Listeria monocytogenes meningitis in a young woman with systemic lupus erythematosus. Rheumatol Int (2010) 0.75
Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet (1988) 7.59
High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. Br J Cancer (2006) 6.59
Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA (2001) 5.99
A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med (1992) 5.96
Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group. Lancet (1999) 4.98
Early antibiotic treatment in acute necrotising pancreatitis. Lancet (1995) 4.86
Mucopurulent cervicitis--the ignored counterpart in women of urethritis in men. N Engl J Med (1984) 4.74
Resistance to erythromycin in group A streptococci. N Engl J Med (1992) 4.42
Cost effectiveness of screening for Chlamydia trachomatis: a review of published studies. Sex Transm Infect (2002) 4.14
Randomised comparison of chloramphenicol, ampicillin, cefotaxime, and ceftriaxone for childhood bacterial meningitis. Finnish Study Group. Lancet (1989) 3.33
Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age. N Engl J Med (1977) 3.32
Different Ly antigen phenotypes of in vitro induced helper and suppressor cells. Nature (1975) 2.91
Polysaccharide vaccines of group A Neisseria meningtitidis and Haemophilus influenzae type b: a field trial in Finland. J Infect Dis (1977) 2.79
Diphtheria after visit to Russia. Lancet (1993) 2.74
Chlamydia trachomatis-induced urethritis in female partners of men with nongonococcal urethritis. Sex Transm Dis (1979) 2.72
Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease. Circulation (1993) 2.70
T-cell lines producing antigen-specific suppressor factor. Nature (1978) 2.63
Bacterial vaginosis in early pregnancy and pregnancy outcome. Obstet Gynecol (1992) 2.36
Plasma level of soluble urokinase-type plasminogen activator receptor as a predictor of disease severity and case fatality in patients with bacteraemia: a prospective cohort study. J Intern Med (2011) 2.29
Association between vaginal douching and acute pelvic inflammatory disease. JAMA (1990) 2.11
Hepatosplenic candidiasis in patients with acute leukemia: incidence and prognostic implications. Clin Infect Dis (1997) 2.08
Suppressor cell induction in vitro. II. Cellular requirements of suppressor cell induction. Eur J Immunol (1976) 2.05
Quality of life and cost-effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial. Lancet (2001) 2.03
Decreased risk of symptomatic chlamydial pelvic inflammatory disease associated with oral contraceptive use. JAMA (1990) 2.02
Molecular epidemiology of Corynebacterium diphtheriae from northwestern Russia and surrounding countries studied by using ribotyping and pulsed-field gel electrophoresis. J Clin Microbiol (1995) 2.00
Genital chlamydial infections in patients attending a gynaecological outpatient clinic. Br J Vener Dis (1978) 1.97
Effect of group-A meningococcal vaccine in army recruits in Finland. Lancet (1975) 1.97
Infections of the central nervous system of suspected viral origin: a collaborative study from Finland. J Neurovirol (2001) 1.96
Role of metronidazole resistance in therapy of Helicobacter pylori infections. Antimicrob Agents Chemother (1992) 1.92
A new gene cluster rfe concerned with the biosynthesis of Salmonella lipopolysaccharide. J Gen Microbiol (1970) 1.91
Comparison of performances of two commercially available tests, a PCR assay and a ligase chain reaction test, in detection of urogenital Chlamydia trachomatis infection. J Clin Microbiol (1998) 1.85
Chlamydial endometritis. J Clin Pathol (1985) 1.80
The seasonal distribution of campylobacter infection in nine European countries and New Zealand. Epidemiol Infect (2002) 1.80
Suppressor-cell induction in vitro. IV. Target of antigen-specific suppressor factor and its genetic relationships. J Exp Med (1978) 1.77
Evaluation of methods for epidemiologic typing of group A streptococci. J Infect Dis (1994) 1.75
Use of antiserum agar plates for serogrouping of meningococci. J Clin Pathol (1977) 1.74
Etiology of cervical inflammation. Am J Obstet Gynecol (1986) 1.72
Safety of probiotics that contain lactobacilli or bifidobacteria. Clin Infect Dis (2003) 1.72
Emergence of fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli in subjects from Finland. Antimicrob Agents Chemother (1991) 1.72
Chlamydia trachomatis in acute salpingitis. Br J Vener Dis (1979) 1.69
Chlamydia trachomatis seroprevalence atlas of Finland 1983-2003. Sex Transm Infect (2007) 1.69
Chlamydia trachomatis in cervicitis and urethritis in women. Scand J Infect Dis Suppl (1982) 1.67
Single-antigen immunofluorescence test for chlamydial antibodies. J Clin Microbiol (1978) 1.66
Midazolam and other benzodiazepines. Handb Exp Pharmacol (2008) 1.66
Suppressor cell induction in vitro. I. Kinetics of induction of antigen-specific suppressor cells. Eur J Immunol (1976) 1.65
Microbiological and histopathological findings in acute pelvic inflammatory disease. Br J Obstet Gynaecol (1987) 1.65
Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. Int J Cancer (2000) 1.58
Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers. BMJ (1997) 1.55
Salmonella in alfalfa sprouts. Lancet (1995) 1.52
Premedication with pregabalin 75 or 150 mg with ibuprofen to control pain after day-case gynaecological laparoscopic surgery. Br J Anaesth (2008) 1.52
Safety of granulocyte colony-stimulating factor (filgrastim) in intubated patients in the intensive care unit: interim analysis of a prospective, placebo-controlled, double-blind study. Crit Care Med (2000) 1.49
Late steroid therapy in primary acute lung injury. Intensive Care Med (2000) 1.49
Lack of association between serum antibodies to Chlamydia trachomatis and a history of recurrent pregnancy loss. Fertil Steril (1999) 1.46
Portfolios as a learning tool in obstetrics and gynaecology undergraduate training. Med Educ (2001) 1.45
Lactobacillus bacteremia, species identification, and antimicrobial susceptibility of 85 blood isolates. Clin Infect Dis (2006) 1.44
A systematic review of the prevalence of Chlamydia trachomatis among European women. Hum Reprod Update (2002) 1.43
Streptococcus mutans establishment and dental caries experience in children from 2 to 4 years old. Scand J Dent Res (1983) 1.41
Anatomic sites of upper genital tract infection. Obstet Gynecol (1985) 1.41
The disc and plate dilution methods in determination of the sensitivity of Neisseria gonorrhoeae to penicillin G, ampicillin and doxycycline. Chemotherapy (1970) 1.41
Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18. Int J Cancer (2011) 1.41
[Osteomyelitis--what old, what new?]. Duodecim (2001) 1.40
Genital Chlamydia trachomatis infections in patients with cervical atypia. Obstet Gynecol (1979) 1.40
Obesity and the risk and outcome of infection. Int J Obes (Lond) (2012) 1.39
T cell responses to PPD in BCG-vaccinated children with insulin-dependent diabetes mellitus and controls. Acta Paediatr (1994) 1.39
Conditions for inducing T helper cells in vitro. Scand J Immunol (1975) 1.39
Evaluation of sampling sites for detection of upper respiratory tract carriage of Streptococcus pneumoniae and Haemophilus influenzae among healthy Filipino infants. J Clin Microbiol (1995) 1.38
C-reactive protein (CRP) and serum phospholipase A2 in the assessment of the severity of acute pancreatitis. Gut (1987) 1.38
Examination of men with nongonococcal urethritis and their sexual partners for Chlamydia trachomatis and Ureaplasma urealyticum. Sex Transm Dis (1979) 1.36
Determination of 19S and 7S components in an anti-hapten antibody. Ann Med Exp Biol Fenn (1967) 1.34
Trends and outcome of nosocomial and community-acquired bloodstream infections due to Staphylococcus aureus in Finland, 1995-2001. Eur J Clin Microbiol Infect Dis (2005) 1.33
Localization of Chlamydia trachomatis infection by direct immunofluorescence and culture in pelvic inflammatory disease. Am J Obstet Gynecol (1986) 1.33
Changes in serum lipoprotein pattern induced by acute infections. Metabolism (1988) 1.32
Serum antibodies and subsequent cervical neoplasms: a prospective study with 12 years of follow-up. Am J Epidemiol (1993) 1.32
Nosocomial bloodstream infections in Finnish hospitals during 1999-2000. Clin Infect Dis (2002) 1.31
The effects of the systemic antimycotics, itraconazole and fluconazole, on the pharmacokinetics and pharmacodynamics of intravenous and oral midazolam. Anesth Analg (1996) 1.31
Persistence of chlamydial antibodies after pelvic inflammatory disease. J Clin Microbiol (1986) 1.29
Mycoplasma hominis in nonspecific vaginitis. Sex Transm Dis (1984) 1.29
Immunoblotting and enzyme-linked immunosorbent assay analysis of serological responses in patients infected with herpes simplex virus types 1 and 2. Intervirology (1985) 1.29
Increase of trimethoprim resistance among Shigella species, 1975-1988: analysis of resistance mechanisms. J Infect Dis (1990) 1.29
HLA DQ alleles and interleukin-10 polymorphism associated with Chlamydia trachomatis-related tubal factor infertility: a case-control study. Hum Reprod (2002) 1.29
Fecal bacteriology and reservoir ileitis in patients operated on for ulcerative colitis. Dis Colon Rectum (1988) 1.29
Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer. J Natl Cancer Inst (1997) 1.29
Healthcare-associated infections in Finnish acute care hospitals: a national prevalence survey, 2005. J Hosp Infect (2008) 1.28
Physiology and ecology of the vagina. Scand J Infect Dis Suppl (1983) 1.28
Chlamydia pneumoniae infection in human monocytes. Infect Immun (1999) 1.28
Smoking and the outcome of infection. J Intern Med (2010) 1.28
An outbreak of Listeria monocytogenes serotype 3a infections from butter in Finland. J Infect Dis (2000) 1.27
Multiple outbreaks of Yersinia pseudotuberculosis infections in Finland. J Clin Microbiol (2004) 1.26
Serological evaluation of herpes simplex virus type 1 and type 2 infections in pregnancy. Sex Transm Infect (1999) 1.24
Beta-haemolytic group A, B, C and G streptococcal septicaemia: a clinical study. Scand J Infect Dis (1988) 1.24
Human papillomavirus infection, risk for subsequent development of cervical neoplasia and associated population attributable fraction. J Clin Virol (2001) 1.23
[Adaptation of a cytomegalic virus from fieldmice (Apodemus sylvaticus) on various heterologous cells, human included]. C R Acad Sci Hebd Seances Acad Sci D (1969) 1.23
Development of beta-lactamase-mediated resistance to penicillin in middle-ear isolates of Moraxella catarrhalis in Finnish children, 1978-1993. Clin Infect Dis (1995) 1.22
CMV infection, class II antigen expression, and human kidney allograft rejection. Transplantation (1986) 1.22
Prevalence and manifestations of endometritis among women with cervicitis. Am J Obstet Gynecol (1985) 1.21